Іздестіру
Treatment
The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care
This toolkit was developed based on WHO Capacity Building Training Package 4 entitled “Strengthening health systems for treating tobacco dependence in primary care”. Its target audience are primary care providers.
Пәкістандағы наркологиялық қызметтердің сапасын қамтамасыз ету (QA)
ISSUP Quality in Trader Network және ISSUP Pacific MNC, UNODC және INL компанияларымен бірлесіп, Пәкістандағы наркологиялық қызметтердің сапасын қамтамасыз ету (QA) бойынша өздерінің вебинарын қуана ұсынады.
Implementación del consejo breve para la reducción del uso de alcohol y tabaco en el primer nivel de atención: Un estudio cualitativo
Introducción: En México el consumo de tabaco y alcohol representa un problema de salud pública. Modelos de tamizaje, intervención breve y referencia a tratamiento (SBIRT) han mostrado eficacia en disminuir dicho consumo, por lo que se...
Фенацетина: Un Adulterante Tóxico Encontrado en Drogas Callejeras Ilegales
Las personas encargadas del tratamiento por abuso de sustancias, quienes ejercen la medicina clínica, los/las extensionistas, las clínicas de salud pública, entre otros, deben conocer la información que se detalla a continuación. La...
Call for Papers: New Drug and other Behavioural Trends During Social-Distancing for the COVID-19 Pandemic
This Special Issue explores new drug and behavioural trends during the Covid-19 Pandemic. We welcome multidisciplinary contributions aimed at enhancing the understanding of how “physical distancing” and other radical changes in our...
Mindfulness-Oriented Recovery Enhancement Remediates Hedonic Dysregulation in Opioid Users: Neural and Affective Evidence of Target Engagement
Abstract
Addiction neuroscience models posit that recurrent drug use increases reactivity to drug-related cues and blunts responsiveness to natural rewards, propelling a cycle of hedonic dysregulation that drives addictive behavior. Here...
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial
Abstract
Importance: Patient-reported outcomes in the treatment of opioid dependence may differ between subcutaneously administered depot buprenorphine and daily sublingual buprenorphine.
Objective: To compare patient satisfaction between...
Staff experiences of encountering and treating outpatients with substance use disorder in the psychiatric context: a qualitative study
Abstract
Background
High comorbidity exists between mental illness and substance use disorders (SUD). Patients in psychiatry living with problematic alcohol or drug consumption can experience a sense of exclusion, where seeking help for...
Cannabis Use in People With Obsessive-Compulsive Symptomatology: Results From a Mexican Epidemiological Sample
Recent studies suggest that the endocannabinoid system could play an important role in the physiopathology of obsessive-compulsive disorder (OCD). There are reports of effective treatment with derivatives of tetrahydrocannabinol (THC). The...
The NIDA Clinical Trials Network: Evolving, Expanding, and Addressing the Opioid Epidemic
Abstract
Over the past two decades, the National Drug Abuse Treatment Clinical Trials Network (CTN), a program of the National Institute on Drug Abuse (NIDA), has expanded from the initial six Nodes to 16 Nodes, as a nationwide consortium...
Addressing Unprecedented Challenges in Management of SUD’s and GBV in the midst of COVID-19
ISSUP Kenya would like to present their Webinar on Addressing Unprecedented Challenges in Management of SUD's and GBV in the midst of COVID-19. The Webinar will explore emerging trends in Substance Use Disorder and Gender-based violence in view of COVID-19 and the correlations between SUD’s and GBV, with special emphasis of the impact of COVID-19.
I Нашақорлықтың алдын алу және емдеу саласындағы мамандардың ұлттық жиналысы
МСЮП Эквадор Сізді «Нашақорлықтың алдын алу және емдеу саласындағы мамандардың I ұлттық жиналысы» екі іс-шарасына шақырғанына қуаныштымын.
HIV/HCV prevalence and risk behavior among NPS users are a growing public health burden
On April 27, 2021, UNODC Regional Office for Central Asia held a training seminar for specialists of the republican and regional levels responsible for drug dependence treatment and HIV prevention services in the Republic of Uzbekistan. The...
Canadian Guidelines on Alcohol Use Disorder Among Older Adults
Open Access article:
Abstract
Background
Alcohol use disorder (AUD) is an increasingly common, under-recognized, and under-treated health concern in older adults. Its prevalence is expected to reach unprecedented levels as the Canadian...
ЮНОДК Түрікменстанда қауіп-қатер тобындағы жастар мен олардың отбасы мүшелеріне қоғамдық негізде әлеуметтік қызмет көрсету бойынша жұмыс күшінің әлеуетін күшейтті
ЮНОДК-ның Орталық Азия бойынша өңірлік басқармасы ЮНОДК-ның Алдын алу, емдеу және оңалту бөлімімен (ТҚҚБ) бірлесіп есірткі тұтынуы бұзылған, оның ішінде қылмыстық сот төрелігі жүйесімен байланыста немесе байланыста болу қаупі бар жастарға...
Екі айлық вебинар: ISSUP Nigeria Knowledge Update Series (Алтыншы сеанс)
ITSUP Нигерия өзінің Bi-Monthly Knowledge Update сериясында келесі Вебинарды ұсынуға қуанышты. Бұл Вебинар «Субстанцияларды пайдаланудың дәлелді алдын алудағы құқық қорғау органдарының рөліне» баса назар аударады.
Qualitative assessment of patients’ perspectives and needs from community pharmacists in substance use disorder management
Abstract
Background
Non-medical use of psychoactive substances is a common harmful behavior that leads to the development of Substance Use Disorders (SUDs). SUD is a significant health concern that causes adverse health consequences and...